New attack on spreading prostate cancer: can zapping the original tumor boost survival?
NCT ID NCT05649943
Summary
This study is for men whose prostate cancer has spread to a few other spots in the body but is still sensitive to hormone-blocking drugs. It aims to see if adding a direct treatment to the prostate itself—like surgery or radiation—on top of standard drug therapy is better at keeping the cancer in check for longer. About 566 participants will be randomly assigned to receive either just the drug therapy or the drug therapy plus one of these local treatments after six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Santi Paolo e Carlo
NOT_YET_RECRUITINGMilan, Lombardy, 20153, Italy
Contact Email: •••••@•••••
Contact
-
European Institute of Oncology
NOT_YET_RECRUITINGMilan, Lombardy, 20141, Italy
Contact Email: •••••@•••••
Contact
-
Istituto Tumori Milano
RECRUITINGMilan, Mi, 20156, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.